Barbara Ann Jacobsmeyer
Insider
First SEC filing: Dec. 30, 2016 · Latest: Jan. 13, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2022 | EHC | A | 22,137 | · | · | 22,137 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 25, 2022 | EHC | A | 9,875 | · | · | 59,539 Direct | +19.88% | Acquired | (price as of 2026-10-02) |
| Feb. 25, 2022 | EHC | A | 5,897 | · | · | 49,664 Direct | +13.47% | Acquired | (price as of 2026-10-02) |
| Feb. 24, 2022 | EHC | F | 584 | $65.52 | $38,264 | 43,767 Direct | -1.32% | Disposed | 129.8% (price as of 2026-10-02) |
| Feb. 22, 2022 | EHC | F | 1,048 | $65.91 | $69,074 | 44,351 Direct | -2.31% | Disposed | 128.5% (price as of 2026-10-02) |
| Jan. 3, 2022 | EHC | F | 3,455 | $65.26 | $225,473 | 45,399 Direct | -7.07% | Disposed | 130.8% (price as of 2026-10-02) |
| March 2, 2021 | EHC | A | 16,620 | · | · | 16,620 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 24, 2021 | EHC | A | 3,943 | · | · | 48,854 Direct | +8.78% | Acquired | (price as of 2026-10-02) |
| Feb. 24, 2021 | EHC | A | 7,536 | · | · | 44,911 Direct | +20.16% | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2021 | EHC | F | 466 | $80.23 | $37,387 | 37,375 Direct | -1.23% | Disposed | 87.7% (price as of 2026-10-02) |
| Feb. 21, 2021 | EHC | F | 505 | $80.51 | $40,658 | 37,841 Direct | -1.32% | Disposed | 87.0% (price as of 2026-10-02) |
| Feb. 20, 2021 | EHC | F | 543 | $80.51 | $43,717 | 38,346 Direct | -1.40% | Disposed | 87.0% (price as of 2026-10-02) |
| Jan. 4, 2021 | EHC | F | 5,872 | $82.69 | $485,556 | 38,889 Direct | -13.12% | Disposed | 82.1% (price as of 2026-10-02) |
| May 15, 2020 | EHC | S | 2,500 | $64.73 | $161,825 | 44,761 Direct | -5.29% | Disposed | 132.6% (price as of 2026-10-02) |
| March 9, 2020 | EHC | G | 1,431 | · | · | 47,261 Direct | -2.94% | Disposed | (price as of 2026-10-02) |
| March 2, 2020 | EHC | A | 17,227 | · | · | 17,227 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 24, 2020 | EHC | F | 466 | $81.64 | $38,044 | 48,692 Direct | -0.95% | Disposed | 84.5% (price as of 2026-10-02) |
| Feb. 21, 2020 | EHC | F | 505 | $81.64 | $41,228 | 49,158 Direct | -1.02% | Disposed | 84.5% (price as of 2026-10-02) |
| Feb. 20, 2020 | EHC | A | 3,669 | · | · | 49,663 Direct | +7.98% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2020 | EHC | A | 13,087 | · | · | 45,994 Direct | +39.77% | Acquired | (price as of 2026-10-02) |
| Feb. 18, 2020 | EHC | F | 500 | $82.61 | $41,305 | 32,907 Direct | -1.50% | Disposed | 82.3% (price as of 2026-10-02) |
| Jan. 2, 2020 | EHC | F | 5,745 | $69.27 | $397,956 | 33,407 Direct | -14.67% | Disposed | 117.4% (price as of 2026-10-02) |
| May 14, 2019 | EHC | G | 2,003 | · | · | 39,152 Direct | -4.87% | Disposed | (price as of 2026-10-02) |
| March 1, 2019 | EHC | A | 14,237 | · | · | 14,237 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 25, 2019 | EHC | F | 466 | $65.87 | $30,695 | 41,155 Direct | -1.12% | Disposed | 128.6% (price as of 2026-10-02) |
| Feb. 21, 2019 | EHC | A | 12,775 | · | · | 41,621 Direct | +44.29% | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2019 | EHC | A | 3,411 | · | · | 28,846 Direct | +13.41% | Acquired | (price as of 2026-10-02) |
| Feb. 19, 2019 | EHC | F | 1,470 | $67.19 | $98,769 | 25,435 Direct | -5.46% | Disposed | 124.1% (price as of 2026-10-02) |
| Jan. 2, 2019 | EHC | F | 5,364 | $61.70 | $330,959 | 26,905 Direct | -16.62% | Disposed | 144.1% (price as of 2026-10-02) |
| May 14, 2018 | EHC | S | 1,798 | $62.73 | $112,789 | 32,269 Direct | -5.28% | Disposed | 140.1% (price as of 2026-10-02) |
| May 2, 2018 | EHC | M | 3,897 | · | · | 7,792 Direct | -33.34% | Disposed | (price as of 2026-10-02) |
| May 2, 2018 | EHC | S | 3,897 | $62.51 | $243,601 | 34,067 Direct | -10.26% | Disposed | 140.9% (price as of 2026-10-02) |
| May 2, 2018 | EHC | M | 3,897 | $42.22 | $164,531 | 37,964 Direct | +11.44% | Acquired | 256.7% (price as of 2026-10-02) |
| March 1, 2018 | EHC | A | 12,151 | · | · | 12,151 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2018 | EHC | A | 11,907 | · | · | 30,918 Direct | +62.63% | Acquired | (price as of 2026-10-02) |
| Feb. 23, 2018 | EHC | A | 3,149 | · | · | 34,067 Direct | +10.19% | Acquired | (price as of 2026-10-02) |
| Feb. 20, 2018 | EHC | F | 1,932 | $52.10 | $100,657 | 19,011 Direct | -9.23% | Disposed | 189.0% (price as of 2026-10-02) |
| Jan. 2, 2018 | EHC | F | 2,156 | $49.41 | $106,528 | 20,943 Direct | -9.33% | Disposed | 204.8% (price as of 2026-10-02) |
| Feb. 24, 2017 | EHC | A | 11,689 | · | · | 11,689 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2017 | EHC | F | 1,521 | $42.00 | $63,882 | 23,099 Direct | -6.18% | Disposed | 258.5% (price as of 2026-10-02) |
| Feb. 17, 2017 | EHC | A | 4,385 | · | · | 24,620 Direct | +21.67% | Acquired | (price as of 2026-10-02) |
| Feb. 17, 2017 | EHC | A | 3,390 | · | · | 20,235 Direct | +20.12% | Acquired | (price as of 2026-10-02) |
| Feb. 14, 2017 | EHC | F | 533 | $41.48 | $22,109 | 16,845 Direct | -3.07% | Disposed | 263.0% (price as of 2026-10-02) |
| Jan. 3, 2017 | EHC | F | 1,762 | $41.24 | $72,665 | 17,378 Direct | -9.21% | Disposed | 265.2% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 1, 2022 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock | $66.39 | March 1, 2032 | 22,137 | Acquired |
| March 2, 2021 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock | $80.40 | March 2, 2031 | 16,620 | Acquired |
| March 2, 2020 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock | $76.54 | March 2, 2030 | 17,227 | Acquired |
| March 1, 2019 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock | $63.77 | March 1, 2029 | 14,237 | Acquired |
| May 2, 2018 | EHC | Non-qualified Stock Option (Right to Buy) | Encompass Health Common Stock | $42.22 | Feb. 24, 2027 | 3,897 | Disposed |
| March 1, 2018 | EHC | Non-qualified Stock Option (Right to Buy) | Healthsouth Common Stock | $53.79 | March 1, 2028 | 12,151 | Acquired |
| Feb. 24, 2017 | EHC | Non-qualified Stock Option (Right to Buy) | Healthsouth Common Stock | $42.22 | Feb. 24, 2027 | 11,689 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 30, 2016 | EHC | Healthsouth Common Stock | 19,140 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $375,000 | · | $1,580,565 | $382,718 | · | · | $37,642 | $2,375,925 |
| 2021 | $703,846 | · | $1,303,548 | $319,295 | $871,386 | · | $143,320 | $3,341,395 |
| 2020 | $620,000 | · | $1,211,485 | $266,742 | $497,250 | · | $26,963 | $2,622,440 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.